Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
TG Therapeutics Inc (NASDAQ: TGTX) closed the day trading at $14.25 up 1.06% from the previous closing price of $14.10. In other words, the price has increased by $1.06 from its previous closing price. On the day, 3.22 million shares were traded. TGTX stock price reached its highest trading level at $14.565 during the session, while it also had its lowest trading level at $14.17.
Ratios:
For a better understanding of TGTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.18 and its Current Ratio is at 5.92. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on August 02, 2023, Upgraded its rating to Neutral and sets its target price to $12 from $16 previously.
On May 20, 2022, BofA Securities started tracking the stock assigning a Underperform rating and target price of $5.BofA Securities initiated its Underperform rating on May 20, 2022, with a $5 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 13 ’24 when Lonial Sagar sold 5,000 shares for $15.94 per share. The transaction valued at 79,675 led to the insider holds 108,878 shares of the business.
Charney Laurence N sold 22,000 shares of TGTX for $351,340 on Mar 12 ’24. The Director now owns 215,229 shares after completing the transaction at $15.97 per share. On Jan 05 ’24, another insider, Charney Laurence N, who serves as the Director of the company, sold 17,500 shares for $19.03 each. As a result, the insider received 333,025 and left with 237,229 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGTX now has a Market Capitalization of 2200499200 and an Enterprise Value of 1935065984. As of this moment, TG’s Price-to-Earnings (P/E) ratio for their current fiscal year is 1010.64, and their Forward P/E ratio for the next fiscal year is 31.67. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.42 while its Price-to-Book (P/B) ratio in mrq is 13.44. Its current Enterprise Value per Revenue stands at 8.281 whereas that against EBITDA is 92.836.
Stock Price History:
Over the past 52 weeks, TGTX has reached a high of $35.67, while it has fallen to a 52-week low of $6.46. The 50-Day Moving Average of the stock is -5.67%, while the 200-Day Moving Average is calculated to be 3.88%.
Shares Statistics:
Over the past 3-months, TGTX traded about 3.50M shares per day on average, while over the past 10 days, TGTX traded about 2871140 shares per day. A total of 151.42M shares are outstanding, with a floating share count of 139.77M. Insiders hold about 9.56% of the company’s shares, while institutions hold 58.76% stake in the company. Shares short for TGTX as of 1711584000 were 34355023 with a Short Ratio of 9.82, compared to 1709164800 on 34841369. Therefore, it implies a Short% of Shares Outstanding of 34355023 and a Short% of Float of 27.27.
